logo

Follow/Share
  • About
  • Careers
  • Events
  • Contact
  • Diversity
  • Alumni
  • English
    • 普通話

Joseph M. Bennett-Paris, Ph.D.

Member

Atlanta
Suite 2200, SunTrust Plaza
303 Peachtree Street, NE
Atlanta, Georgia 30308
P
(404) 572-2024
TF
(800) 890-1393
F
(404) 572-2199
  • People
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z
    • |
    • View all people



  • Industries
    • Energy & Utilities
    • Food & Beverage
    • Gaming
    • Health Care & Life Sciences
    • Insurance
    • Media, Entertainment & Sports
    • Real Estate & Construction
    • Technology
    • Transportation & Logistics
    • Venture Capital
  • Practice Areas
      • Antitrust & Trade Regulation
      • Bankruptcy, Insolvency & Restructuring
      • China Practice
      • Corporate
      • Emerging Business & Venture Capital
      • Energy, Environmental & Public Utilities
      • Health Care
      • International
      • Mergers & Acquisitions
      • Private Client Services
      • Public & Project Finance
      • Securities
      • Tax
      • Transportation & Logistics
      Business/Corporate
      • Antitrust & Trade Regulation
      • Aviation
      • Consumer Protection & Privacy
      • Cozen O'Connor Public Strategies - Government Relations
      • Energy, Environmental & Public Utilities
      • Health Care
      • Privacy & Data Security
      • Transportation & Logistics
      Government & Regulatory
      • Bad Faith
      • Cyber/Technology
      • Insurance Corporate & Regulatory
      • Insurance Coverage & Claims Litigation
      • Professional Liability Insurance Coverage
      • Reinsurance
      • Subrogation & Recovery
      Insurance
      • Biologics/Biosimilars
      • Domains
      • e-commerce
      • Entertainment Law
      • Franchising
      • Hatch-Waxman Litigation
      • Intellectual Property Litigation
      • Licensing & Transfer
      • Patents
      • Right of Privacy & Right of Publicity
      • Trade Secrets & Unfair Competition
      • Trademark & Copyright
      Intellectual Property
      • Employee Benefits & Executive Compensation
      • Employment Litigation
      • Immigration
      • Labor Relations & Disputes
      • Trade Secrets & Unfair Competition
      Labor & Employment
      • Antitrust Litigation & Investigations
      • Appellate
      • Aviation
      • Bankruptcy, Insolvency & Restructuring
      • Complex Litigation
      • Construction
      • Criminal Defense & Internal Investigations
      • Cyber/Technology
      • Electronic Discovery
      • Energy, Environmental & Public Utilities
      • Family Law
      • Franchise Disputes
      • Health Care
      • Insurance Coverage & Claims Litigation
      • Intellectual Property Litigation
      • Products Liability
      • Professional Liability
      • Real Estate Litigation
      • Securities Litigation & Enforcement
      • Self-insured Recovery
      • Transportation & Logistics Litigation
      Litigation
      • Brownfields Development
      • Distressed Real Estate
      • Eminent Domain
      • Office/Retail/Industrial Leasing & Development
      • Real Estate Finance
      • Real Estate Litigation
      • Zoning, Land Use & Development
      Real Estate
      • Subrogation & Recovery
    • Experience
      • Client Stories
      • Experience
    • Offices
      • Atlanta
      • New York
      • Charlotte
      • Philadelphia
      • Cherry Hill
      • San Diego
      • Chicago
      • Seattle
      • Dallas
      • Toronto
      • Denver
      • Washington, D.C.
      • Harrisburg
      • West Conshohocken
      • Houston
      • West Palm Beach
      • London
      • Wilkes-Barre
      • Los Angeles
      • Wilmington
      • Miami
    • News & Resources
      • Blogs
      • News & Resources
      • Media Resources
      • Publications
    • OVERVIEW
    • EXPERIENCE
    • NEWS

    Joseph M. Bennett-Paris, Ph.D.

    Joseph M. Bennett-Paris, Ph.D, joined the firm's Intellectual Property Practice Group in 2012 and practices in the Atlanta office. Joseph counsels clients in matters of patent prosecution, non-infringement, patentability, invalidity, and various other legal issues.

    Joseph primarily focuses his practice on the biotechnology and pharmaceutical industries with specific emphasis on the generic drug industry. His practice also includes copyright matters and entertainment law, particularly with regard to the music and publishing industries. In addition, he provides pro bono work to the arts community through the Georgia Lawyers for the Arts.

    He is a member of the Intellectual Property Law Section of the American Bar Association and the Atlanta and Georgia State bar associations and is a Preceptor for the Mercer University School of Pharmacy.  Prior to entering law, he served on the faculty of the Wake Forest University School of Medicine.

    Joseph is a 1999 graduate of the University of North Carolina School of Law and a graduate of Loyola University Chicago (Ph.D., pharmacology) and the University of Southern California (B.S., biological sciences).

     

    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Medicis' acne product SOLODYN® (minocycline hydrochloride).


    Lead counsel for Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Endo's pain product OPANA® ER (oxymorphone hydrochloride).


    Represented Apotex Inc., in a patent infringement action regarding Apotex's ANDA to make a generic version of Wyeth's anti-depressant product EFFEXOR XR® (venlafaxine hydrochloride). Settled on favorable terms during trial.


    Represented Apotex Inc., in a patent infringement action regarding Apotex's ANDA to make a generic version of Sanofi-Aventis' anticancer product TAXOTERE®, the active ingredient of which is docetaxel. Following a two-week trial, obtained an order for Apotex striking down the patents-in-issue as invalid as obvious and unenforceable due to Sanofi-Aventis' inequitable conduct in procuring the patents. Successfully argued on appeal with the Federal Circuit affirming trial court decision (April 2012). Of import is that inequitable conduct defense remains viable in ANDA litigations because of this ruling.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Allergan's glaucoma drops COMBIGAN® (brimonidine tartrate/timolol maleate.)


    Represented Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Merck's anti-nausea product EMEND® (aprepitant).


    Designed and implemented the litigation strategy as lead counsel for defendant, a Taiwanese semiconductor manufacturer, in a patent infringement case involving DC/AC power inverters for LCD panels in portable electronic devices. The defense resulted in a judgment as a matter of law on the issues of direct and contributory infringement and plaintiff's abandonment of a $120 million-plus damage claim (jury finding of inducement was reversed on appeal).


    Represented Chimei InnoLux Corporation, f/k/a InnoLux Display Corporation, in a patent infringement case involving brightness-enhancing films used in LCD devices. Plaintiff dismissed its case against our client, with prejudice, after the special master indicated he would recommend granting defendant's motion for summary judgment.


    Represented our client in a patent infringement action regarding Actavis' ANDA to make a generic version of King's pain product AVINZA®, the active ingredient of which is morphine sulfate.


    Represented our client, Mylan Pharmaceuticals, Inc., in a patent infringement action regarding Mylan's ANDA to make a generic version of Pfizer's cardiovascular product CADUET®, the active ingredients of which are atorvastatin calcium and amlodipine besylate. Settled prior to trial.


    Represented Apotex Inc., in a patent infringement action regarding Apotex's ANDA to make a generic version of Procter's osteoporosis product ACTONEL® (risedronate).


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Abbott’s ZEMPLAR® (paricalcitol).


    Represented Apotex Inc., in a patent infringement action regarding Apotex’s ANDA to make a generic version of LYSTEDA (tranexamic acid). Matter pending.


    Represented Apotex Inc., in a patent infringement action regarding Apotex’s ANDA to make a generic version of ACULAR LS® (0.4% ketorolac tromethamine). Matter pending.


    Represented Apotex Inc., in a patent infringement action regarding Apotex’s ANDA to make a generic version of PRISTIQ® (desvenlafaxine). Matter pending.


    Represented Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Shire’s ADHD product INTUNIV® (guanfacine hydrochloride). Matter pending.


    Represented Sandoz Inc., in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Roche’s VALCYTE® (valganciclovir hydrochloride). Matter pending.


    Represented our client, Sandoz Inc., in patent infringement action regarding Sandoz’s ANDA to make a generic version of Helsinn’s anti-nausea product ALOXI® (palonosetron hydrochloride injection). Matter pending.


    Represented our client in a patent infringement action regarding InnoPharma’s ANDA to make a generic version of Spectrum’s FUSILEV® (levoleucovorin). Matter pending.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Abbott’s cholesterol medication TRILIPIX® (fenofibric acid). Matter pending.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz’s ANDA to make a generic version of Abbott’s cholesterol product NIASPAN® (niacin). Matter pending.


    Represented our client, Sandoz Inc., in a patent infringement action regarding Sandoz's ANDA to make a generic version of Alcon's eye allergy product PATANOL® (olopatadine hydrochloride).


    Represented client CardSoft in patent infringement action against multiple defendants who manufactured and sold infringing electronic point-of-sale ("ePOS") terminals using “swipe-technology.” Successfully secured patent damages for client in excess of $15 million for CardSoft in jury trial against VeriFone Systems, Inc. and VeriFone, Inc. (VeriFone) and Hypercom Corp. (Hypercom).


    Represented our client in a patent infringement action regarding Apotex’s ANDA to make a generic version of AVODART® (dutasteride). Matter pending.


    Additional Practices

    News


    Cozen O’Connor Continues Growth of IP Litigation Practice with Seven Partners, Two Associates from Duane Morris

    April 16, 2012

    Cozen O’Connor Continues Growth of IP Litigation Practice with Seven Partners, Two Associates from Duane Morris

    MORE

    Publications

    There are no PUBLICATIONS at this time. Please try back at a later time.

    Practice Areas

    Biologics/Biosimilars

    Hatch-Waxman Litigation

    Intellectual Property

    Education

    • University of North Carolina School of Law ;, J.D., 1999
    • Loyola University Chicago;, Ph.D.;, 1988
    • University of Southern California;, B.S.;, 1983

    Bar Admissions

    • Georgia
    • United States Patent and Trademark Office

    Court Admissions

    • Georgia Court of Appeals
    • Georgia Supreme Court
    • U.S. Court of Appeals for the Eleventh Circuit
    • U.S. Court of Appeals for the Federal Circuit
    • U.S. District Court -- Northern District of Georgia
    • Sitemap
    • Advanced Search
    • Disclaimer
    • Privacy Policy
    • Attorney Advertising